Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Biocept Says Antonino Morales Tendered His Resignation As Company's President And Chief Executive Officer Effective On October 13, 2023; Assets Of Company Will Be Liquidated And Any Claims Paid In Accordance With Code

Author: Benzinga Newsdesk | October 16, 2023 09:00am

- SEC Filing

Posted In: BIOC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist